PRZOOM - /newswire/ -
Monrovia, CA, United States, 2008/08/08 - GTCbio just announced its inaugural Bugs & Drugs conference – one of the leading forums to address unmet medical needs for problematic microbials - taking place on September 22-23, 2008 in San Diego, CA.
Infections are becoming increasingly problematic due to the recent resistances to current antibiotics. Patients suffering from resistant bugs (hospital-acquired or community-acquired) now need new yet unavailable treatments to combat their infections.
The Bugs & Drugs conference brings together leading experts to discuss current options available in combating these problematic pathogens and the current drugs in development that may resolve these issues. Included are discussions on various gram positive & negative drugs, contingency plans for biological weapons & disease outbreaks, novel delivery methods, regulatory aspects & clinical trial design, and novel drug developments for diseases of developing economies.
Keynote & featured presenters include Barry Eisenstein, Senior Vice President of Scientific Affairs at Cubit Pharmaceuticals and Clinical Professor of Medicine at Harvard Medical School, Sharath Hegde, Vice President of Pharmacology at Theravance and Rita Helfand, Associate Director of Epidemiologic Science at the National Center for Preparedness, Detection, and Control of Infectious Diseases, the Centers for Disease Control and Prevention.
GTCbio (gtcbio.com) organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.